Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

October 31, 1998

Conditions
Lymphoma
Interventions
DIETARY_SUPPLEMENT

bismuth subcitrate

DRUG

amoxicillin

DRUG

clarithromycin

DRUG

metronidazole hydrochloride

DRUG

omeprazole

DRUG

tetracycline hydrochloride

Trial Locations (22)

BA1 3NG

Royal United Hospital, Bath

B15 2TA

University Birmingham N.H.S. Trust, Birmingham

NW3 2QG

Royal Free Hospital, Hampstead, London

LS9 7TF

St. James's Hospital, Leeds

EC1A 7BE

Saint Bartholomew's Hospital, London

NW3 2PF

Royal Free Hospital School of Medicine, London

SE1 7EH

Guy's, King's and St. Thomas' Hospitals Trust, London

SW3 6JJ

Royal Marsden NHS Trust, London

W12 ONN

Hammersmith Hospital, London

W1N 8AA

Middlesex Hospital- Meyerstein Institute, London

W6 8RF

Charing Cross Hospital, London

L63 4JY

Clatterbridge Centre for Oncology NHS Trust, Merseyside

NE4 6BE

Newcastle General Hospital, Newcastle upon Tyne

HA6 2RN

Mount Vernon Hospital, Northwood

NG5 1PB

Nottingham City Hospital NHS Trust, Nottingham

0X3 7LJ

Oxford Radcliffe Hospital, Oxford

SO14 0YG

Royal South Hants Hospital, Southampton

SM2 5PT

Royal Marsden Hospital, Sutton

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

EH4 9NQ

Western General Hospital, Edinburgh

G11 6NT

Beatson Oncology Centre, Glasgow

G4 0SF

Royal Infirmary, Glasgow

All Listed Sponsors
collaborator

University of Glasgow

OTHER

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00003151 - Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma | Biotech Hunter | Biotech Hunter